(1)
Alessandra Fusco; Sara Colarusso; Marco Piscopo; Maria Rosaria Improta; Marco Corigliano. Short-Term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience. HROJ 2017, 4, 46-56.